2023
DOI: 10.1002/ddr.22080
|View full text |Cite
|
Sign up to set email alerts
|

New pyrrole derivatives as DNA gyrase and 14α‐demethylase inhibitors: Design, synthesis, antimicrobial evaluation, and molecular docking

Khaled M. H. Hilmy,
Fawzya N. M. Kishk,
Esmat B. A. Shahen
et al.

Abstract: An efficient one‐pot reaction utilizing readily available chemical reagents was used to prepare novel 2‐amino‐1,5‐diaryl‐1H‐pyrrole‐3‐carbonitrile derivatives and the structures of these compounds were validated by spectroscopic data and elemental analyses. All the synthetic compounds were evaluated for their antimicrobial activities (MZI assay). The tested compounds proved high activities on Staphylococcus aureus (Gram‐positive bacteria) and Candida albicans (Pathogenic fungi). However, they did not show any … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 49 publications
0
1
0
Order By: Relevance
“…This concept has motivated researchers to discover many antifungals that inhibit 14-αdemethylase activity. 48,49 The target compounds (ligand and its complexes) showed experimentally antifungal activities against C. albicans, and the Co (II) complex showed boosted activity that confirms the role of the complexation on the enhancement of the activity of the ligand concerning the reference ketoconazole. The binding interaction of the ligand and its Co (II) complex on CYP51 may support that hypothesis.…”
Section: Docking As Antifungal Agentsmentioning
confidence: 70%
“…This concept has motivated researchers to discover many antifungals that inhibit 14-αdemethylase activity. 48,49 The target compounds (ligand and its complexes) showed experimentally antifungal activities against C. albicans, and the Co (II) complex showed boosted activity that confirms the role of the complexation on the enhancement of the activity of the ligand concerning the reference ketoconazole. The binding interaction of the ligand and its Co (II) complex on CYP51 may support that hypothesis.…”
Section: Docking As Antifungal Agentsmentioning
confidence: 70%